PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1224479
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1224479
Biomarker Testing Services Market with COVID-19 Impact Analysis, By Service, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Biomarker Testing Services Market size was valued at USD 830.6 Million in 2022, expanding at a CAGR of 7.8% from 2023 to 2030.
A laboratory technique that examines a sample of tissue, blood, or other bodily fluid for certain genes, proteins, or other substances that may be a symptom of a disease or illness, such as cancer. Biomarker testing can also be used to look for abnormalities in a person's gene or chromosome that may raise their chance of acquiring cancer or other disorders. Biomarker testing may be used with other procedures, such as biopsies, to aid in the diagnosis of certain forms of cancer. It may also be used to aid in treatment planning, determining how well treatment is working, making a prognosis, or predicting if cancer will return or spread to other places of the body. Molecular profiling and testing are other terms for the same thing.
Biomarker Testing Services Market- Market Dynamics
Growing investment in pharmaceutical R&D, the rising need for precision medicine utilized in cancer therapy, and an increase in the burden of infectious and chronic diseases fueling demand for biomarker testing are some of the primary drivers driving market expansion. Moreover, clinical trials have been steadily increasing during the previous five years. According to ClinicalTrials.gov, more than 262,298 studies were registered in 2018, while more than 399,518 trials were registered as of September 2022. Clinical trials are projected to improve in the future years as clinical research funding increases. This is predicted to increase demand for drug discovery research and, as a result, demand for biomarker testing in the post-pandemic era.
In addition, through the use of biomarker testing, several biopharmaceutical firms are attempting to increase the detection rate of cancer patients. For instance, the Biomarker Assist Program was introduced by the biopharmaceutical company Amgen in April 2021. This initiative offered biomarker testing to patients with metastatic (stage IV) non-small cell lung cancer (NSCLC) to screen for the presence of oncogene biomarkers that aid in targeted therapy. Such actions taken by market participants are probably going to aid in the market's expansion.
Biomarker Testing Services Market- Segmentation Analysis:
Based on the service, the biomarker assay development & validation segment is expected to hold the largest market share over the forecast period. The increasing volume of clinical research and drug discovery activities that demand the development and validation of biomarker assays is one of the main factors promoting the segment's expansion. In 2018, the FDA approved 40.0% of customized medications based on biomarkers, which increases demand for the development and validation of biomarker assays. For detecting biomarkers in cancer disorders, there is an increasing demand for companion diagnostics such as immunohistochemistry kits. For instance, Roche's VENTANA MMR RxDx Panel IHC panel, which is used to identify biomarkers in patients with endometrial cancer, obtained clearance in August 2022. This reinforces the need for the creation of biomarker assays.
Based on the end user, the pharmaceutical and biotechnology companies segment is expected to grow significantly over the forecast period. One of the main factors driving the segment's growth is a rise in the funding provided by the pharmaceutical and biotechnology industries for clinical research. Additionally, pharmaceutical firms are becoming more interested in creating cancer-focused medicines. Due to this, AstraZeneca and Roche partnered in September 2022 to reimagine cancer detection and treatment across the Middle East and North Africa. The alliance aimed to lower obstacles to biomarker testing and increase regional access to precision medications.
Biomarker Testing Services Market- Geographical Insights
North America is expected to dominate the market during the forecast period. The factors supporting the market in the region include the presence of major market players offering biomarker testing services there, an increase in disease burden that causes a rise in laboratory diagnostic testing, the presence of sophisticated healthcare infrastructure, and growing R&D investment by public organizations in the region. For instance, the 2020 study on COVID-19 biomarkers was supported by USD 78,000 from the Canadian government. Finding biomarkers for COVID-19 severity identification was the goal of the study.
Biomarker Testing Services Market- Recent Development:
In June 2022, to increase its biomarker testing capabilities in Japan, Labcorp and BML announced their partnership. The alliance will increase Labcorp's global reach.
Key features of the study:
This proposed research study on the Biomarker Testing Services market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for ` the Biomarker Testing Services market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain the Biomarker Testing Services market
The impact of COVID-19 on the Biomarker Testing Services market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Biomarker Testing Services market post-COVID will also be covered.
To give the users of this report a comprehensive view of the Biomarker Testing Services market, we have also included a competitive landscape and key innovator analysis for the Biomarker Testing Services market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Biomarker Testing Services market.
In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.
The global Biomarker Testing Services market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOMARKER TESTING SERVICES MARKET KEY PLAYERS
Charles River Laboratories
IQVIA
SGS SA
Bio Agilytix Labs
Labcorp Drug Development
Intertek Group Plc
ICON Plc
Euro fins Scientific
Syneos Health
Thermo Fisher Scientific Inc.
GLOBAL BIOMARKER TESTING SERVICES MARKET, BY SERVICE
Biomarker Assay Development
Flow Cytometry
Others
GLOBAL BIOMARKER TESTING SERVICES MARKET, BY END USER
Pharmaceutical and biotechnology companies
Research Institutes
CRO
GLOBAL BIOMARKER TESTING SERVICES MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
TABLE OF CONTENT
1. Biomarker Testing Services Market Overview
- 1.1. Study Scope
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Biomarker Testing Services Market Snippet by Service
- 2.1.2. Biomarker Testing Services Market Snippet by End User
- 2.1.3. Biomarker Testing Services Market Snippet by Country
- 2.1.4. Biomarker Testing Services Market Snippet by Region
- 2.2. Competitive Insights
3. Biomarker Testing Services Key Market Trends
- 3.1. Biomarker Testing Services Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Biomarker Testing Services Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Biomarker Testing Services Market Opportunities
- 3.4. Biomarker Testing Services Market Future Trends
4. Biomarker Testing Services Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Biomarker Testing Services Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Biomarker Testing Services Market Landscape
- 6.1. Biomarker Testing Services Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Biomarker Testing Services Market - By Service
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Service, 2022 & 2030 (%)
- 7.1.2. Biomarker Assay Development
- 7.1.3. Flow Cytometry
- 7.1.4. Others
8. Biomarker Testing Services Market - By End User
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
- 8.1.2. Pharmaceutical and biotechnology companies
- 8.1.3. Research Institutes
- 8.1.4. CRO
9. Biomarker Testing Services Market- By Geography
- 9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 9.2. North America
- 9.2.1. Overview
- 9.2.2. Biomarker Testing Services Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.2.7. U.S.
- 9.2.7.1. Overview
- 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.7.3. U.S. Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.2.7.4. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.2.8. Canada
- 9.2.8.1. Overview
- 9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.8.3. Canada Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.2.8.4. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3. Europe
- 9.3.1. Overview
- 9.3.2. Biomarker Testing Services Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.6. Germany
- 9.3.6.1. Overview
- 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.6.3. Germany Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.3.6.4. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.7. Italy
- 9.3.7.1. Overview
- 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.7.3. Italy Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.3.7.4. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.8. United Kingdom
- 9.3.8.1. Overview
- 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.8.3. United Kingdom Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.3.8.4. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.9. France
- 9.3.9.1. Overview
- 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.9.3. France Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.3.9.4. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.10. Russia
- 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.10.2. Russia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.3.10.3. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.11. Netherlands
- 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.11.2. Netherlands Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.3.11.3. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.12. Sweden
- 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.12.2. Sweden Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.3.12.3. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.13. Poland
- 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.13.2. Poland Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.3.13.3. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.3.14. Rest of Europe
- 9.3.14.1. Overview
- 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.14.3. Rest of the Europe Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.3.14.4. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Biomarker Testing Services Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.6. India
- 9.4.6.1. Overview
- 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.6.3. India Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.4.6.4. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.7. China
- 9.4.7.1. Overview
- 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.7.3. China Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.4.7.4. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.8. Japan
- 9.4.8.1. Overview
- 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.8.3. Japan Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.4.8.4. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.9. South Korea
- 9.4.9.1. Overview
- 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.9.3. South Korea Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.4.9.4. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.10. Australia
- 9.4.10.1. Overview
- 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.10.3. Australia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.4.10.4. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.11. Thailand
- 9.4.11.1. Overview
- 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.11.3. Thailand Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.4.11.4. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.12. Indonesia
- 9.4.12.1. Overview
- 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.12.3. Indonesia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.4.12.4. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.13. Philippines
- 9.4.13.1. Overview
- 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.13.3. Philippines Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.4.13.4. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.4.14. Rest of APAC
- 9.4.14.1. Overview
- 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.14.3. Rest of APAC Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.4.14.4. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Biomarker Testing Services Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.5.6. Brazil
- 9.5.6.1. Overview
- 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.6.3. Brazil Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.5.6.4. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.5.7. Mexico
- 9.5.7.1. Overview
- 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.7.3. Mexico Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.5.7.4. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.5.8. Argentina
- 9.5.8.1. Overview
- 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.8.3. Argentina Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.5.8.4. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.5.9. Colombia
- 9.5.9.1. Overview
- 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.9.3. Colombia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.5.9.4. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.5.10. Rest of LATAM
- 9.5.10.1. Overview
- 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.10.3. Rest of LATAM Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.5.10.4. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Biomarker Testing Services Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6.6. Saudi Arabia
- 9.6.6.1. Overview
- 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.6.3. Saudi Arabia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.6.6.4. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6.7. United Arab Emirates
- 9.6.7.1. Overview
- 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.7.3. United Arab Emirates Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.6.7.4. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6.8. Israel
- 9.6.8.1. Overview
- 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.8.3. Israel Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.6.8.4. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6.9. Turkey
- 9.6.9.1. Overview
- 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.9.3. Turkey Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.6.9.4. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6.10. Algeria
- 9.6.10.1. Overview
- 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.10.3. Algeria Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.6.10.4. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6.11. Egypt
- 9.6.11.1. Overview
- 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.11.3. Egypt Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.6.11.4. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 9.6.12. Rest of MEA
- 9.6.12.1. Overview
- 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.12.3. Rest of MEA Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
- 9.6.12.4. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Biomarker Testing Services Industry
- 10.1. Competitive Dashboard
- 10.2. Company Profiles
- 10.2.1. Charles River Laboratories
- 10.2.2. IQVIA
- 10.2.3. SGS SA
- 10.2.4. Bio Agilytix Labs
- 10.2.5. Labcorp Drug Development
- 10.2.6. Intertek Group Plc
- 10.2.7. ICON Plc
- 10.2.8. Euro fins Scientific
- 10.2.9. Syneos Health
- 10.2.10. Thermo Fisher Scientific Inc.
11. 360 Degree Analyst View
12. Appendix
- 12.1. Research Methodology
- 12.2. References
- 12.3. Abbreviations
- 12.4. Disclaimer
- 12.5. Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Biomarker Testing Services Market:Service Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Service
- TABLE Global Biomarker Testing Services Market, by Service 2018-2030 (USD Million)
- TABLE Biomarker Testing Services Market: Regional snapshot (2022)
- TABLE Biomarker Testing Services Market: End User Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by End User
- TABLE Global Biomarker Testing Services Market, by End User 2018-2030 (USD Million)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Biomarker Testing Services Market, by Region 2018-2030 (USD Million)
- TABLE North America Biomarker Testing Services Market, by Country, 2018-2030 (USD Million)
- TABLE North America Biomarker Testing Services Market, by Service, 2018-2030 (USD Million)
- TABLE North America Biomarker Testing Services Market, by End User, 2018-2030 (USD Million)
- TABLE Europe Biomarker Testing Services Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Biomarker Testing Services Market, by Service, 2018-2030 (USD Million)
- TABLE Europe Biomarker Testing Services Market, by End User, 2018-2030 (USD Million)
- TABLE Asia Pacific Biomarker Testing Services Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Biomarker Testing Services Market, by Service, 2018-2030 (USD Million)
- TABLE Asia Pacific Biomarker Testing Services Market, by End User, 2018-2030 (USD Million)
- TABLE Latin America Biomarker Testing Services Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Biomarker Testing Services Market, by Service, 2018-2030 (USD Million)
- TABLE Latin America Biomarker Testing Services Market, by End User, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biomarker Testing Services Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biomarker Testing Services Market, by Service, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biomarker Testing Services Market, by Application, 2018-2030 (USD Million)
- TABLE Middle East and Africa Biomarker Testing Services Market, by End User, 2018-2030 (USD Million)
